Funded PhD Opportunities
We offer a diverse range of fully funded PhD projects each year, including Clinical, Non-Clinical, and MB-PhD programmes. Use our filter below to explore our PhD opportunities.
 
            Targeting small cell lung cancer plasticity and heterogeneity to tackle metastasis and drug resistance
 
            Identifying vulnerabilities of E-cadherin-deficient tumour cells to uncover novel treatment approaches for lobular breast cancer
 
            Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cancer prevention through weight loss: emulating a target trial and mediation analysis
 
            GENERATION: Improving the efficiency and equity of tumour-agnostic clinical trial recruitment using automated electronic record based tools
 
            Investigating the role of semaglutide (GLP-1 receptor agonist) in the medical management of atypical endometrial hyperplasia and endometrial cancer
 
            Developing novel therapeutics to target splicing factor mutant myeloid malignancies
 
            Identifying epigenetic regulatory mechanisms conferring chemotherapeutic drug resistance in oesophageal adenocarcinoma
 
            Deep profiling of non-small cell lung cancer clinical samples to identify and validate novel mechanisms of resistance to KRAS inhibition
 
            Investigating the influence of the aged microbiome on the immune response to cancer
 
            The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer
 
            Beyond BRCA1/2: dissecting drivers of chromosome instability in high-grade serous ovarian cancer
 
    